(DYN) |
| 0 (0%) 06-09 21:12 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 22.90 |
| Resistance 1: | 19.60 |
| Pivot price: | 17.76 |
| Support 1: | 17.30 |
| Support 2: | 15.87 |
| 52w High: | |
| 52w Low: |
| EPS | -3.150 |
| Book Value | 5.890 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -32.7 |
| Return on Equity (ttm) | -58.9 |
Tue, 09 Jun 2026
Director at Dyne Therapeutics (DYN) receives 35,152 stock options - Stock Titan
Tue, 09 Jun 2026
Director Lubner gets 35,152 Dyne (DYN) options at $17.04 strike - Stock Titan
Mon, 08 Jun 2026
Ja'Dyn Williams - On3
Mon, 08 Jun 2026
Dyne Therapeutics (DYN) Is Down 9.8% After Doubling Share Authorization Amid Key Rare Disease Milestones - simplywall.st
Fri, 05 Jun 2026
Dyne Therapeutics (DYN) Reaches Key Regulatory Milestone - Yahoo Finance
Thu, 04 Jun 2026
Flower Mound-Based Healthcare Payments Co. CMSPricer Acquired by Delaware's Micro‑Dyn - Dallas Innovates
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |